Be clear on high-risk drugs to achieve OASIS accuracy, avoid bad outcomes

Effective Feb 22, 2023
Published Feb 22, 2023
Last Reviewed Feb 22, 2023
The new OASIS-E item N0415 (High-risk drug classes: use and indication) might mean that clinicians need a reminder for additional documentation to explain why it’s needed and whether there are any indications.
Subscription Required

You must log in to view the content you requested.

Not a subscriber? Start accessing the article you’re seeking right away plus weekly, home health-specific news, analysis, guidance and specific tools that enable your agency to increase referrals and profitability during times of increased competition and regulatory scrutiny.
Need multi-user access? Ensure uninterrupted individual access and maximum coding productivity for your whole team. For site license inquiries call: 1-800-650-6787

Subscribers receive 12 monthly issues of the Home Health Line to help them:

  • Comply with the latest CMS regulations
  • Boost referrals with effective marketing and sales tactics
  • Recruit and retain talented clinicians and administrative staff
  • Improve productivity with time-saving strategies
  • Steer clear of anti-kickback and Stark violations
  • Benchmark your agency against competitors
  • Cut costs with smart operational practices

Home Health Line and its companion website, homehealthline.com, are the home health 30-DAY 100% No-Risk Guarantee — By using the tips, tools and expert business-boosting guidance you receive as a subscriber, you will increase revenue and decrease costs enough to more than cover your subscription cost or we’ll refund your subscription fee!

Login

User Name:
Password: